A red-hot US jobs report slammed Oracle shares on Friday, triggering a 8.89% slide that wiped out weeks of gains. But rather than triggering a uniform retreat, the sell-off has laid bare one of the widest analyst divergences in recent memory: BTIG Research sees the stock doubling to $400, while RBC Capital pegs fair value at $190—barely above current levels.
The stark contrast underscores the binary risk facing Oracle as it prepares to report fiscal fourth-quarter results on June 10. The options market is already pricing a swing of roughly 12% in either direction after the release.
Jobs Shock Resets Rate Expectations
Friday’s rout was sparked by a Labor Department report showing the US economy added 172,000 nonfarm jobs in May—more than double the 85,000 economists had anticipated. The unemployment rate held steady at 4.3%. For the tech sector, the data was poison: robust hiring gives the Federal Reserve little reason to cut rates soon, and higher discount rates disproportionately punish high-growth valuations. Oracle lost 9.6% at one point, while the broader technology sector shed 6.7%.
Despite the brutal finish, the stock still sits 12.29% higher over the past 30 days and has gained 11.05% year to date. It has rallied nearly 63% from its February low of €113.86, when the “SaaSpocalypse” triggered by Anthropic’s AI agents sent software stocks into a tailspin.
What’s at Stake on Wednesday
RBC Capital raised its price target from $160 to $190 after the sell-off but kept its neutral rating, calling the move a “peer-relative valuation adjustment” rather than a fundamental conviction upgrade. The bank outlined five key variables for the upcoming earnings: Oracle’s multiyear capital expenditure plan, data center expansion velocity, GPU cluster deployments, the financial implications of the Stargate project, and the sustainability of free cash flow.
On the other side of the divide, BTIG reiterated its “buy” rating and $400 target, arguing that Oracle’s massive cloud infrastructure investments are building a durable competitive moat. Mizuho has a $320 target, Cantor Fitzgerald lifted its to $284, and Citi pushed to $330. Of the 42 analysts covering the stock, 32 recommend “buy.”
Should investors sell immediately? Or is it worth buying Oracle?
The Numbers Behind the Bet
Oracle’s third-quarter results—for the period ended February 2026—set a high bar. Total revenue hit $17.2 billion, up 22% year over year. Cloud revenue surged 44% to $8.9 billion, with Oracle Cloud Infrastructure alone growing 84%. The remaining performance obligations—a gauge of future contracted revenue—soared 325% to $553 billion, driven by large-scale AI deals.
Yet the capital required to fulfill those contracts is enormous. Oracle plans to spend $50 billion on infrastructure in the current fiscal year, against a revenue target of $67 billion. The company aims to reach $90 billion in revenue by 2027, but the escalating capital intensity has investors questioning margins.
Stargate, Arm, and the Cost-Cutting Coda
The macro-driven sell-off overshadowed a week rich with corporate news. On June 1, Oracle joined OpenAI for the groundbreaking of the $16 billion “Stargate” campus in Michigan—dubbed “The Barn”—which will house three data centers with over one gigawatt of capacity. Financing comes from equity contributions by Related Digital and Blackstone alongside fixed-rate debt from PIMCO.
Separately, Arm CEO René Haas confirmed at Computex that Oracle Cloud Infrastructure is among the first customers for Arm’s new AGI CPUs, alongside ByteDance, Cerebras, and OpenAI. Meanwhile, Oracle’s previously announced workforce reduction of up to 30,000 employees—roughly 18% of the workforce—is nearing completion, with the last notice periods expiring on June 15.
The Big Question
With the stock trading at €185.46 and having pulled back 4.17% over the past week, the immediate focus shifts to Wednesday’s numbers. Investors will be watching for more than just revenue growth—they want evidence that Oracle’s cloud engine can generate sustainable free cash flow without requiring constant capital injections. The answer, whichever way it goes, is likely to settle the debate between the $400 bulls and the $190 bears.
Ad
Oracle Stock: Buy or Sell?! New Oracle Analysis from June 6 delivers the answer:
The latest Oracle figures speak for themselves: Urgent action needed for Oracle investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from June 6.
Oracle: Buy or sell? Read more here...
